tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PVLA Stock Latest News

Palvella Therapeutics launches ‘BEYOND mLM’ disease awareness campaign
The FlyPalvella Therapeutics launches ‘BEYOND mLM’ disease awareness campaign
6d ago
PVLA
Palvella Therapeutics price target raised to $220 from $200 at Clear Street
PremiumThe Fly
Palvella Therapeutics price target raised to $220 from $200 at Clear Street
14d ago
PVLA
Palvella Therapeutics price target raised to $220 from $200 at Chardan
PremiumThe Fly
Palvella Therapeutics price target raised to $220 from $200 at Chardan
14d ago
PVLA
Palvella Therapeutics Announces Underwritten Common Stock Offering
PremiumCompany Announcements
Palvella Therapeutics Announces Underwritten Common Stock Offering
17d ago
8K
PVLA
Palvella Therapeutics 1.6M share Secondary priced at $125.00
PremiumThe Fly
Palvella Therapeutics 1.6M share Secondary priced at $125.00
18d ago
PVLA
Palvella Therapeutics price target raised to $250 from $205 at Mizuho
PremiumThe FlyPalvella Therapeutics price target raised to $250 from $205 at Mizuho
19d ago
PVLA
Palvella Therapeutics price target raised to $215 from $192 at BTIG
Premium
The Fly
Palvella Therapeutics price target raised to $215 from $192 at BTIG
19d ago
PVLA
Robust Phase 3 SELVA Results for QTORIN Rapamycin Drive Confident Buy Rating on PVLA
Premium
Ratings
Robust Phase 3 SELVA Results for QTORIN Rapamycin Drive Confident Buy Rating on PVLA
19d ago
PVLA
Palvella Therapeutics announces $150M proposed public offering of common stock
PremiumThe Fly
Palvella Therapeutics announces $150M proposed public offering of common stock
19d ago
PVLA
Palvella Therapeutics price target raised to $210 from $190 at Truist
PremiumThe Fly
Palvella Therapeutics price target raised to $210 from $190 at Truist
20d ago
PVLA
Palvella Therapeutics price target raised to $209 from $143 at JonesResearch
PremiumThe Fly
Palvella Therapeutics price target raised to $209 from $143 at JonesResearch
20d ago
PVLA
Palvella Therapeutics price target raised to $210 from $174 at Chardan
PremiumThe Fly
Palvella Therapeutics price target raised to $210 from $174 at Chardan
20d ago
PVLA
Ligand price target raised to $239 from $231 at H.C. Wainwright
PremiumThe FlyLigand price target raised to $239 from $231 at H.C. Wainwright
20d ago
LGND
PVLA
Palvella Therapeutics price target raised to $250 from $180 at Stifel
Premium
The Fly
Palvella Therapeutics price target raised to $250 from $180 at Stifel
20d ago
PVLA
Palvella Therapeutics price target raised to $255 from $200 at H.C. Wainwright
Premium
The Fly
Palvella Therapeutics price target raised to $255 from $200 at H.C. Wainwright
20d ago
PVLA
Palvella Reports Positive Phase 3 Data for QTORIN Gel
PremiumCompany Announcements
Palvella Reports Positive Phase 3 Data for QTORIN Gel
20d ago
8K
PVLA
Palvella Reports Positive Phase 3 Data for QTORIN
PremiumCompany Announcements
Palvella Reports Positive Phase 3 Data for QTORIN
20d ago
8K
PVLA
Palvella Therapeutics’ qtorin meets primary endpoint in lymphatic malformations
PremiumThe Fly
Palvella Therapeutics’ qtorin meets primary endpoint in lymphatic malformations
20d ago
PVLA
Palvella Therapeutics (PVLA): Mechanistic Validation, Unmet Need, and Pivotal Trial Catalysts Underpin Buy Rating
PremiumRatings
Palvella Therapeutics (PVLA): Mechanistic Validation, Unmet Need, and Pivotal Trial Catalysts Underpin Buy Rating
1M ago
PVLA
Palvella Therapeutics management to meet virtually with Craig-Hallum
PremiumThe FlyPalvella Therapeutics management to meet virtually with Craig-Hallum
1M ago
PVLA
Palvella Therapeutics price target raised to $190 from $133 at TD Cowen
Premium
The Fly
Palvella Therapeutics price target raised to $190 from $133 at TD Cowen
1M ago
PVLA
Palvella Therapeutics announces publication of review on Qtorin
Premium
The Fly
Palvella Therapeutics announces publication of review on Qtorin
1M ago
PVLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >